U Magazine
U Magazine
UCLA Health
David Geffen School of Medicine


On December 13, 2012, a reception and check presentation were held at the Frank Clark Urology Center at the Peter Morton Medical Building (200 UCLA Medical Plaza) in celebration of a $4.6-million gift to the Department of Urology from the Frank W. and Dorothy H. Clark Estate. According to Mr. Matthew Grossman, trustee, this amount represents approximately half of the bequest. UCLA will receive the remainder when the estate is settled. Mr. and Mrs. Clark played a critical role not only in the creation of the Clark Urology Centers in Westwood and Santa Monica, but also in the establishment of the Division of Pediatric Urology. Mr. Clark was the major donor to the Clark-Morrison Children's Urological Center and was a close advisor to the Department of Urology throughout his life.

George and Ruth Moss made a gener-ous donation to the Jules Stein Eye Institute (JSEI) to benefit ophthalmic-oncology research and treatment. The Mosses' gift supports the work of Dr. Tara A. McCannel, assistant professor of ophthalmology and director of JSEI's Ophthalmic Oncology Center. During a routine eye examination in 2006, Mr. Moss's ophthalmologist discovered an ocular melanoma - a malignant tumor - and Mr. Moss was referred to Dr. McCannel for treat-ment. She is one of the few surgeons in the nation with expertise in a less-radical surgical option - destroying the tumor through high doses of radiation while trying to save the eye. Mr. Moss did lose sight in the treated eye, but he is cancer-free. Dr. McCannel says, "Because of this support, research can be conducted that results in discovery, progress in the care and treatment of patients, and cures within the field."

The Department of Urology has received $385,000 from the Jean Perkins Foundation. Specifically, $210,000 was awarded to Dr. Leonard S. Marks for 1) the purchase of a state-of-the-art ultrasound machine to be used for guidance of tissue-ablative fibers into the prostate gland to destroy cancerous lesions deemed appropriate for focal therapy and 2) support of a biomedical engineering graduate student for two years. The engineering aspects of this new treatment modality will be a major portion of the student's PhD thesis material. In addition, the foundation awarded $175,000 to Dr. Isla Garraway to develop novel tissue regeneration models that will allow for the further evaluation of prostate tumors induced by cells of origin. Understanding the developmental state of the prostate cell that is most susceptible to tumor initiation will enable biomarkers to be identified and evaluated as tools for predicting cancer risk and severity, which could improve the interpretation of prostate biopsies. The Jean Perkins Foundation has provided critical resources to equip Dr. Garraway's laboratory and support personnel since 2006.

Phase One Foundation has awarded $452,350 to the UCLA Department of Urology to fund two research projects in keeping with the foundation's mission to transform a terminal illness into one where patients can live a full and productive life. Dr. Karim Chamie, assistant professor of urology, will receive $142,350 over two years to investigate the use of a novel polymer in the detection and treatment of urothelial carcinoma. Dr. Joseph Riss, assistant professor and director of research for the Kidney Cancer Program, will receive $310,000 over three years to study how the efficacy and applicability of a novel vaccine for metastatic renal-cell carcinoma can be enhanced. UCLA has benefited greatly due to grants from Phase One Foundation, which has allowed UCLA urologists to make excellent progress toward better treatments for urologic cancers.

Texas oil executive and philanthropist T. Boone Pickens (second from right) Mr. Pickens is pictured here with Dr. David T. Feinberg (left), president of UCLA Health, patient Army Captain James Barclay and Dr.Christopher Crisera, co-medical director of Operation Mend.Texas oil executive and philanthropist T. Boone Pickens (second from right) recently hosted a reception at the Dallas Country Club to bring awareness of UCLA Operation Mend to his Texas friends and colleagues. Mr. Pickens is pictured here with Dr. David T. Feinberg (left), president of UCLA Health, patient Army Captain James Barclay and Dr. Christopher Crisera, co-medical director of Operation Mend, at the event. The T. Boone Pickens Foundation made an initial gift of $500,000 to Operation Mend, with a promise of long-term support for this unique UCLA colla-borative partnership with the military.

Dr. Jacqueline Casillas (left), program director, and Myra Porter, Auxiliary president.The UCLA Health Auxiliary recently granted its largest gift to date, $1 million, to the newly opened Daltrey/Townshend Teen and Young Adult Zone located on the sixth floor of UCLA Medical Center, Santa Monica. Pictured at the entrance is Dr. Jacqueline Casillas (left), program director, and Myra Porter, Auxiliary president. The "Zone" is the core component of the Daltrey/Townshend Teen and Young Adult Cancer Program, the first one in the U.S. It is modeled after multiple Teen Cancer Trust units in the U.K., which have been supported and championed by Roger Daltrey and Pete Townshend, founding members of the legendary rock band The Who. Since 1955, the Auxiliary, known as the "heart" of UCLA hospitals, has provided more than $11 million to UCLA patients and programs, primarily through profits from its gift and thrift shops and member support.Photo: Becky Mancuso-Winding

The David Geffen School of Medicine at UCLA has received a gift of more than $2 million from the estate of Robert T. Vigen, BA '61, MD '67. In keeping with Dr. Vigen's wishes, this contribution will advance trans-lational melanoma research under the direction of Dr. Antoni Ribas at the Jonsson Comprehensive Cancer Center.

The Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA has received a $5.5-million bequest from the Wilder Family Trust. Two-million dollars will establish the Billy and Audrey Wilder Endowed Chair in Psychiatry and Neuroscience. The remaining $3.5 million will be allocated to the Wilder Family Trust Fund, with revenue supporting research, senior psychiatry residents and postdoctoral fellows, as well as capital programs at the discretion of the director of the Semel Institute.


Add a comment

Please note that we are unable to respond to medical questions. For information about health care, or if you need help in choosing a UCLA physician, please contact UCLA Physician Referral Service (PRS) at 1-800-UCLA-MD1 (1-800-825-2631) and ask to speak with a referral nurse. Thank you.